An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.
Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for variability in disease outcome. A cohort of sporadic MS cases (n = 163), taken from opposite extremes of the distribution of long-term outcome, was used to determine the role of the HLA-DRB1 locus...
| Egile Nagusiak: | , , , , , , , , , , , , , |
|---|---|
| Formatua: | Journal article |
| Hizkuntza: | English |
| Argitaratua: |
2007
|
| _version_ | 1826273021672816640 |
|---|---|
| author | DeLuca, G Ramagopalan, S Herrera, B Dyment, D Lincoln, MR Montpetit, A Pugliatti, M Barnardo, M Risch, N Sadovnick, A Chao, M Sotgiu, S Hudson, T Ebers, G |
| author_facet | DeLuca, G Ramagopalan, S Herrera, B Dyment, D Lincoln, MR Montpetit, A Pugliatti, M Barnardo, M Risch, N Sadovnick, A Chao, M Sotgiu, S Hudson, T Ebers, G |
| author_sort | DeLuca, G |
| collection | OXFORD |
| description | Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for variability in disease outcome. A cohort of sporadic MS cases (n = 163), taken from opposite extremes of the distribution of long-term outcome, was used to determine the role of the HLA-DRB1 locus on MS disease severity. Genotyping sets of benign and malignant MS patients showed that HLA-DRB1*01 was significantly underrepresented in malignant compared with benign cases. This allele appears to attenuate the progressive disability that characterizes MS in the long term. The observation was doubly replicated in (i) Sardinian benign and malignant patients and (ii) a cohort of affected sibling pairs discordant for HLA-DRB1*01. Among the latter, mean disability progression indices were significantly lower in those carrying the HLA-DRB1*01 allele compared with their disease-concordant siblings who did not. The findings were additionally supported by similar transmission distortion of HLA-DRB1*04 subtypes closely related to HLA-DRB1*01. The protective effect of HLA-DRB1*01 in sibling pairs may result from a specific epistatic interaction with the susceptibility allele HLA-DRB1*1501. A high-density (>700) SNP examination of the MHC region in the benign and malignant patients could not identify variants differing significantly between the two groups, suggesting that HLA-DRB1 may itself be the disease-modifying locus. We conclude that HLA-DRB1*01, previously implicated in disease resistance, acts as an independent modifier of disease progression. These results closely link susceptibility to long-term outcome in MS, suggesting that shared quantitative MHC-based mechanisms are common to both, emphasizing the central role of this region in pathogenesis. |
| first_indexed | 2024-03-06T22:21:49Z |
| format | Journal article |
| id | oxford-uuid:554f31b2-6d79-4849-9e65-ca83e6094a77 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:21:49Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:554f31b2-6d79-4849-9e65-ca83e6094a772022-03-26T16:43:14ZAn extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:554f31b2-6d79-4849-9e65-ca83e6094a77EnglishSymplectic Elements at Oxford2007DeLuca, GRamagopalan, SHerrera, BDyment, DLincoln, MRMontpetit, APugliatti, MBarnardo, MRisch, NSadovnick, AChao, MSotgiu, SHudson, TEbers, GMultiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for variability in disease outcome. A cohort of sporadic MS cases (n = 163), taken from opposite extremes of the distribution of long-term outcome, was used to determine the role of the HLA-DRB1 locus on MS disease severity. Genotyping sets of benign and malignant MS patients showed that HLA-DRB1*01 was significantly underrepresented in malignant compared with benign cases. This allele appears to attenuate the progressive disability that characterizes MS in the long term. The observation was doubly replicated in (i) Sardinian benign and malignant patients and (ii) a cohort of affected sibling pairs discordant for HLA-DRB1*01. Among the latter, mean disability progression indices were significantly lower in those carrying the HLA-DRB1*01 allele compared with their disease-concordant siblings who did not. The findings were additionally supported by similar transmission distortion of HLA-DRB1*04 subtypes closely related to HLA-DRB1*01. The protective effect of HLA-DRB1*01 in sibling pairs may result from a specific epistatic interaction with the susceptibility allele HLA-DRB1*1501. A high-density (>700) SNP examination of the MHC region in the benign and malignant patients could not identify variants differing significantly between the two groups, suggesting that HLA-DRB1 may itself be the disease-modifying locus. We conclude that HLA-DRB1*01, previously implicated in disease resistance, acts as an independent modifier of disease progression. These results closely link susceptibility to long-term outcome in MS, suggesting that shared quantitative MHC-based mechanisms are common to both, emphasizing the central role of this region in pathogenesis. |
| spellingShingle | DeLuca, G Ramagopalan, S Herrera, B Dyment, D Lincoln, MR Montpetit, A Pugliatti, M Barnardo, M Risch, N Sadovnick, A Chao, M Sotgiu, S Hudson, T Ebers, G An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. |
| title | An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. |
| title_full | An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. |
| title_fullStr | An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. |
| title_full_unstemmed | An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. |
| title_short | An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. |
| title_sort | extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the hla drb1 locus |
| work_keys_str_mv | AT delucag anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT ramagopalans anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT herrerab anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT dymentd anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT lincolnmr anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT montpetita anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT pugliattim anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT barnardom anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT rischn anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT sadovnicka anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT chaom anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT sotgius anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT hudsont anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT ebersg anextremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT delucag extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT ramagopalans extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT herrerab extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT dymentd extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT lincolnmr extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT montpetita extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT pugliattim extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT barnardom extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT rischn extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT sadovnicka extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT chaom extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT sotgius extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT hudsont extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus AT ebersg extremesofoutcomestrategyprovidesevidencethatmultiplesclerosisseverityisdeterminedbyallelesatthehladrb1locus |